Trial Outcomes & Findings for Injectable Diclofenac for the Prevention of Post-operative Dental Pain (NCT NCT01706588)

NCT ID: NCT01706588

Last Updated: 2014-09-05

Results Overview

Pain will be scored by the patient at the end of surgery (time 0) and at 15-minute intervals after surgery for a total of 6 hours on a 0-100 mm VAS (from 0 = no pain to 100 = worst pain imaginable).

Recruitment status

COMPLETED

Study phase

PHASE2

Target enrollment

75 participants

Primary outcome timeframe

Pain scores will be measured over the time from end of surgery (time 0) to the 6 hour post-surgery

Results posted on

2014-09-05

Participant Flow

Participant milestones

Participant milestones
Measure
Diclofenac Sodium 5 mg/mL
Diclofenac sodium: One single diclofenac injection into the surgical area before surgery but as soon as the anaesthetic has taken effect.
Diclofenac Sodium 12.5 mg/mL
Diclofenac sodium: One single diclofenac injection into the surgical area before surgery but as soon as the anaesthetic has taken effect.
Diclofenac Sodium 25 mg/mL
Diclofenac sodium: One single diclofenac injection into the surgical area before surgery but as soon as the anaesthetic has taken effect.
Diclofenac Sodium 50 mg/mL
Diclofenac sodium: One single diclofenac injection into the surgical area before surgery but as soon as the anaesthetic has taken effect.
Placebo 1 mL
One single placebo injection into the surgical area before surgery but as soon as the anaesthetic has taken effect.
Overall Study
STARTED
15
15
15
14
16
Overall Study
COMPLETED
15
15
15
14
16
Overall Study
NOT COMPLETED
0
0
0
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Injectable Diclofenac for the Prevention of Post-operative Dental Pain

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Diclofenac Sodium 5 mg/mL
n=15 Participants
Diclofenac sodium: One single diclofenac injection into the surgical area before surgery but as soon as the anaesthetic has taken effect.
Diclofenac Sodium 12.5 mg/mL
n=15 Participants
Diclofenac sodium: One single diclofenac injection into the surgical area before surgery but as soon as the anaesthetic has taken effect.
Diclofenac Sodium 25 mg/mL
n=15 Participants
Diclofenac sodium: One single diclofenac injection into the surgical area before surgery but as soon as the anaesthetic has taken effect.
Diclofenac Sodium 50 mg/mL
n=14 Participants
Diclofenac sodium: One single diclofenac injection into the surgical area before surgery but as soon as the anaesthetic has taken effect.
Placebo 1 mL
n=16 Participants
One single placebo injection into the surgical area before surgery but as soon as the anaesthetic has taken effect.
Total
n=75 Participants
Total of all reporting groups
Age, Continuous
28 years
STANDARD_DEVIATION 7.3 • n=5 Participants
28 years
STANDARD_DEVIATION 9.4 • n=7 Participants
30 years
STANDARD_DEVIATION 9 • n=5 Participants
27 years
STANDARD_DEVIATION 4.5 • n=4 Participants
30 years
STANDARD_DEVIATION 9.5 • n=21 Participants
28.6 years
STANDARD_DEVIATION 7.94 • n=8 Participants
Sex: Female, Male
Female
9 Participants
n=5 Participants
6 Participants
n=7 Participants
12 Participants
n=5 Participants
8 Participants
n=4 Participants
12 Participants
n=21 Participants
47 Participants
n=8 Participants
Sex: Female, Male
Male
6 Participants
n=5 Participants
9 Participants
n=7 Participants
3 Participants
n=5 Participants
6 Participants
n=4 Participants
4 Participants
n=21 Participants
28 Participants
n=8 Participants

PRIMARY outcome

Timeframe: Pain scores will be measured over the time from end of surgery (time 0) to the 6 hour post-surgery

Pain will be scored by the patient at the end of surgery (time 0) and at 15-minute intervals after surgery for a total of 6 hours on a 0-100 mm VAS (from 0 = no pain to 100 = worst pain imaginable).

Outcome measures

Outcome measures
Measure
Diclofenac Sodium 5 mg/mL
n=15 Participants
Diclofenac sodium: One single diclofenac injection into the surgical area before surgery but as soon as the anaesthetic has taken effect.
Diclofenac Sodium 12.5 mg/mL
n=15 Participants
Diclofenac sodium: One single diclofenac injection into the surgical area before surgery but as soon as the anaesthetic has taken effect.
Diclofenac Sodium 25 mg/mL
n=15 Participants
Diclofenac sodium: One single diclofenac injection into the surgical area before surgery but as soon as the anaesthetic has taken effect.
Diclofenac Sodium 50 mg/mL
n=14 Participants
Diclofenac sodium: One single diclofenac injection into the surgical area before surgery but as soon as the anaesthetic has taken effect.
Placebo 1 mL
n=16 Participants
One single placebo injection into the surgical area before surgery but as soon as the anaesthetic has taken effect.
Area Under the Curve (AUC) of the Pain Scores.
6843 mm*minutes
Standard Deviation 6259
8832 mm*minutes
Standard Deviation 6330
9998 mm*minutes
Standard Deviation 8080
7290 mm*minutes
Standard Deviation 6509
15539 mm*minutes
Standard Deviation 9279

SECONDARY outcome

Timeframe: measured at 6 hours postsurgery, at day 3 and 1 week postsurgery

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: measured at 6 hours postsurgery, at day 3 and 1 week postsurgery

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: measured from end of surgery up to 12 hours postsurgery

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: measured from end of surgery up to 1 week postsurgery

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: consumed by the patient every 15-minutes postsurgery up to 6 hours postsurgery

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: consumed by the patient from end of surgery up to 24 and up to 48 hours postsurgery

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: at 6 hour postsurgery and on Day 3

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: measured from end of surgery up to 12 hours postsurgery

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: at 6 hour postsurgery, and on day 3 and 1 week postsurgery

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: every hour up to 6 hour postsurgery

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: presurgery (within 30 days from surgery), at day of surgery (day 1), day 3 and 1 week postsurgery.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: from signature of the informed consent to 1 week postsurgery

Outcome measures

Outcome data not reported

Adverse Events

Diclofenac Sodium 5 mg/mL

Serious events: 0 serious events
Other events: 6 other events
Deaths: 0 deaths

Diclofenac Sodium 12.5 mg/mL

Serious events: 0 serious events
Other events: 7 other events
Deaths: 0 deaths

Diclofenac Sodium 25 mg/mL

Serious events: 0 serious events
Other events: 5 other events
Deaths: 0 deaths

Diclofenac Sodium 50 mg/mL

Serious events: 0 serious events
Other events: 5 other events
Deaths: 0 deaths

Placebo 1 mL

Serious events: 0 serious events
Other events: 6 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Diclofenac Sodium 5 mg/mL
n=15 participants at risk
Diclofenac sodium: One single diclofenac injection into the surgical area before surgery but as soon as the anaesthetic has taken effect.
Diclofenac Sodium 12.5 mg/mL
n=15 participants at risk
Diclofenac sodium: One single diclofenac injection into the surgical area before surgery but as soon as the anaesthetic has taken effect.
Diclofenac Sodium 25 mg/mL
n=15 participants at risk
Diclofenac sodium: One single diclofenac injection into the surgical area before surgery but as soon as the anaesthetic has taken effect.
Diclofenac Sodium 50 mg/mL
n=14 participants at risk
Diclofenac sodium: One single diclofenac injection into the surgical area before surgery but as soon as the anaesthetic has taken effect.
Placebo 1 mL
n=16 participants at risk
One single placebo injection into the surgical area before surgery but as soon as the anaesthetic has taken effect.
Ear and labyrinth disorders
ear pain
13.3%
2/15 • Number of events 2
6.7%
1/15 • Number of events 1
0.00%
0/15
7.1%
1/14 • Number of events 1
0.00%
0/16
Gastrointestinal disorders
vomiting
13.3%
2/15 • Number of events 2
0.00%
0/15
13.3%
2/15 • Number of events 2
0.00%
0/14
6.2%
1/16 • Number of events 1
General disorders
injection site pain
13.3%
2/15 • Number of events 2
13.3%
2/15 • Number of events 2
26.7%
4/15 • Number of events 5
7.1%
1/14 • Number of events 1
0.00%
0/16
General disorders
swelling
6.7%
1/15 • Number of events 2
0.00%
0/15
0.00%
0/15
0.00%
0/14
0.00%
0/16
Nervous system disorders
headache
26.7%
4/15 • Number of events 4
0.00%
0/15
0.00%
0/15
7.1%
1/14 • Number of events 1
12.5%
2/16 • Number of events 4
Musculoskeletal and connective tissue disorders
pain in jaw
0.00%
0/15
26.7%
4/15 • Number of events 4
0.00%
0/15
0.00%
0/14
12.5%
2/16 • Number of events 2
Nervous system disorders
dizziness
0.00%
0/15
13.3%
2/15 • Number of events 2
0.00%
0/15
0.00%
0/14
0.00%
0/16
General disorders
injection site swelling
0.00%
0/15
0.00%
0/15
13.3%
2/15 • Number of events 2
0.00%
0/14
0.00%
0/16
Blood and lymphatic system disorders
linphadenopathy
0.00%
0/15
0.00%
0/15
0.00%
0/15
7.1%
1/14 • Number of events 1
0.00%
0/16
Gastrointestinal disorders
nausea
0.00%
0/15
0.00%
0/15
0.00%
0/15
7.1%
1/14 • Number of events 1
12.5%
2/16 • Number of events 2
Gastrointestinal disorders
gingival ulceration
0.00%
0/15
0.00%
0/15
0.00%
0/15
7.1%
1/14 • Number of events 1
0.00%
0/16
Injury, poisoning and procedural complications
procedural pain
0.00%
0/15
0.00%
0/15
0.00%
0/15
7.1%
1/14 • Number of events 1
0.00%
0/16
Nervous system disorders
lethargy
0.00%
0/15
0.00%
0/15
0.00%
0/15
7.1%
1/14 • Number of events 1
0.00%
0/16
Nervous system disorders
somnolence
0.00%
0/15
0.00%
0/15
0.00%
0/15
7.1%
1/14 • Number of events 1
0.00%
0/16
Respiratory, thoracic and mediastinal disorders
oropharyngeal pain
0.00%
0/15
0.00%
0/15
0.00%
0/15
7.1%
1/14 • Number of events 1
6.2%
1/16 • Number of events 1
Gastrointestinal disorders
diarrhoea
0.00%
0/15
0.00%
0/15
0.00%
0/15
0.00%
0/14
6.2%
1/16 • Number of events 1
Infections and infestations
wound infection
0.00%
0/15
0.00%
0/15
0.00%
0/15
0.00%
0/14
6.2%
1/16 • Number of events 1
Musculoskeletal and connective tissue disorders
joint stiffness
0.00%
0/15
0.00%
0/15
0.00%
0/15
0.00%
0/14
6.2%
1/16 • Number of events 1
Vascular disorders
hot flush
0.00%
0/15
0.00%
0/15
0.00%
0/15
0.00%
0/14
6.2%
1/16 • Number of events 1

Additional Information

Prof. Thomas Dietrich

The School of Dentistry, University of Birmingham

Phone: +44-121-46 65494

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place

Restriction type: LTE60